Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

Vaginal-perineal cultures for detecting group B streptococci and extended spectrum β-lactamase producing bacteria in pregnancy.

Huang DJ, Hösli I, Tschudin-Sutter S, Pfister T, Granado C, Müller-Borer D, Schötzau A, Frei R, Dangel M, Huhn EA, Widmer A, Vuichard-Gysin D.

Eur J Obstet Gynecol Reprod Biol. 2019 Oct;241:24-29. doi: 10.1016/j.ejogrb.2019.07.024. Epub 2019 Jul 19.

PMID:
31437621
2.

Environmental Risk Assessment for the Active Pharmaceutical Ingredient Mycophenolic Acid in European Surface Waters.

Straub JO, Oldenkamp R, Pfister T, Häner A.

Environ Toxicol Chem. 2019 Oct;38(10):2259-2278. doi: 10.1002/etc.4524. Epub 2019 Sep 19.

PMID:
31225916
3.

A comparison of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae bloodstream infections in Alberta using a provincial surveillance system.

Bush KR, Ellison J, Hearn K, Pfister T, Taylor G.

Infect Control Hosp Epidemiol. 2019 Mar;40(3):388. doi: 10.1017/ice.2018.353. Epub 2019 Feb 18. No abstract available.

PMID:
30773162
4.

Safety and tolerability of transition from inhaled treprostinil to oral selexipag in pulmonary arterial hypertension: Results from the TRANSIT-1 study.

Frost A, Janmohamed M, Fritz JS, McConnell JW, Poch D, Fortin TA, Miller CE, Chin KM, Fisher M, Eggert M, McEvoy C, Benza RL, Farber HW, Kim NH, Pfister T, Shiraga Y, McLaughlin V.

J Heart Lung Transplant. 2019 Jan;38(1):43-50. doi: 10.1016/j.healun.2018.09.003. Epub 2018 Sep 12.

5.

Use of the permitted daily exposure (PDE) concept for contaminants of intravitreal (IVT) drugs in multipurpose manufacturing facilities.

Lovsin Barle E, Pfister T, Fux C, Röthlisberger D, Jere D, Mahler HC.

Regul Toxicol Pharmacol. 2019 Feb;101:29-34. doi: 10.1016/j.yrtph.2018.10.007. Epub 2018 Oct 24.

PMID:
30367903
6.

A three-dimensional hybrid pacemaker electrode seamlessly integrates into engineered, functional human cardiac tissue in vitro.

Weigel T, Schmitz T, Pfister T, Gaetzner S, Jannasch M, Al-Hijailan R, Schürlein S, Suliman S, Mustafa K, Hansmann J.

Sci Rep. 2018 Sep 28;8(1):14545. doi: 10.1038/s41598-018-32790-8.

7.

Novel antibody reagents for characterization of drug- and tumor microenvironment-induced changes in epithelial-mesenchymal transition and cancer stem cells.

Navas T, Pfister TD, Colantonio S, Aziz A, Dieckman L, Saul RG, Kaczmarczyk J, Borgel S, Alcoser SY, Hollingshead MG, Lee YH, Bottaro DP, Hiltke T, Whiteley G, Takebe N, Kinders RJ, Parchment RE, Tomaszewski JE, Doroshow JH.

PLoS One. 2018 Jun 21;13(6):e0199361. doi: 10.1371/journal.pone.0199361. eCollection 2018.

8.

Comparison of two accelerometers for measuring physical activity and sedentary behaviour.

Pfister T, Matthews CE, Wang Q, Kopciuk KA, Courneya K, Friedenreich C.

BMJ Open Sport Exerc Med. 2017 May 12;3(1):e000227. doi: 10.1136/bmjsem-2017-000227. eCollection 2017.

9.

The root causes of pharmacodynamic assay failure.

Ferry-Galow KV, Makhlouf HR, Wilsker DF, Lawrence SM, Pfister TD, Marrero AM, Bigelow KM, Yutzy WH, Ji JJ, Butcher DO, Gouker BA, Kummar S, Chen AP, Kinders RJ, Parchment RE, Doroshow JH.

Semin Oncol. 2016 Aug;43(4):484-91. doi: 10.1053/j.seminoncol.2016.06.006. Epub 2016 Jun 15. Review.

PMID:
27663480
10.

Toxicokinetic and toxicodynamic considerations when deriving health-based exposure limits for pharmaceuticals.

Reichard JF, Maier MA, Naumann BD, Pecquet AM, Pfister T, Sandhu R, Sargent EV, Streeter AJ, Weideman PA.

Regul Toxicol Pharmacol. 2016 Aug;79 Suppl 1:S67-78. doi: 10.1016/j.yrtph.2016.05.027. Epub 2016 May 22. Review.

PMID:
27224509
11.

A harmonization effort for acceptable daily exposure derivation - Considerations for application of adjustment factors.

Sussman RG, Naumann BD, Pfister T, Sehner C, Seaman C, Weideman PA.

Regul Toxicol Pharmacol. 2016 Aug;79 Suppl 1:S57-66. doi: 10.1016/j.yrtph.2016.05.023. Epub 2016 May 21. Review.

PMID:
27221789
12.

Clinical and pharmacologic evaluation of two dosing schedules of indotecan (LMP400), a novel indenoisoquinoline, in patients with advanced solid tumors.

Kummar S, Chen A, Gutierrez M, Pfister TD, Wang L, Redon C, Bonner WM, Yutzy W, Zhang Y, Kinders RJ, Ji J, Allen D, Covey JM, Eiseman JL, Holleran JL, Beumer JH, Rubinstein L, Collins J, Tomaszewski J, Parchment R, Pommier Y, Doroshow JH.

Cancer Chemother Pharmacol. 2016 Jul;78(1):73-81. doi: 10.1007/s00280-016-2998-6. Epub 2016 May 11.

13.

Nailfold Videocapillaroscopic Features and Other Clinical Risk Factors for Digital Ulcers in Systemic Sclerosis: A Multicenter, Prospective Cohort Study.

Cutolo M, Herrick AL, Distler O, Becker MO, Beltran E, Carpentier P, Ferri C, Inanç M, Vlachoyiannopoulos P, Chadha-Boreham H, Cottreel E, Pfister T, Rosenberg D, Torres JV, Smith V; CAP Study Investigators.

Arthritis Rheumatol. 2016 Oct;68(10):2527-39. doi: 10.1002/art.39718.

14.

Characterization of DNA topoisomerase I in three SN-38 resistant human colon cancer cell lines reveals a new pair of resistance-associated mutations.

Jensen NF, Agama K, Roy A, Smith DH, Pfister TD, Rømer MU, Zhang HL, Doroshow JH, Knudsen BR, Stenvang J, Brünner N, Pommier Y.

J Exp Clin Cancer Res. 2016 Mar 31;35:56. doi: 10.1186/s13046-016-0335-x.

15.

Pharmacodynamic Response of the MET/HGF Receptor to Small-Molecule Tyrosine Kinase Inhibitors Examined with Validated, Fit-for-Clinic Immunoassays.

Srivastava AK, Hollingshead MG, Weiner J, Navas T, Evrard YA, Khin SA, Ji JJ, Zhang Y, Borgel S, Pfister TD, Kinders RJ, Bottaro DP, Linehan WM, Tomaszewski JE, Doroshow JH, Parchment RE.

Clin Cancer Res. 2016 Jul 15;22(14):3683-94. doi: 10.1158/1078-0432.CCR-15-2323. Epub 2016 Mar 21.

16.

Enhancing Mn(II)-Binding and Manganese Peroxidase Activity in a Designed Cytochrome c Peroxidase through Fine-Tuning Secondary-Sphere Interactions.

Hosseinzadeh P, Mirts EN, Pfister TD, Gao YG, Mayne C, Robinson H, Tajkhorshid E, Lu Y.

Biochemistry. 2016 Mar 15;55(10):1494-502. doi: 10.1021/acs.biochem.5b01299. Epub 2016 Mar 2.

17.

The incidence of concussion in youth sports: a systematic review and meta-analysis.

Pfister T, Pfister K, Hagel B, Ghali WA, Ronksley PE.

Br J Sports Med. 2016 Mar;50(5):292-7. doi: 10.1136/bjsports-2015-094978. Epub 2015 Nov 30. Review.

PMID:
26626271
18.

Contribution of new technologies to characterization and prediction of adverse effects.

Rouquié D, Heneweer M, Botham J, Ketelslegers H, Markell L, Pfister T, Steiling W, Strauss V, Hennes C.

Crit Rev Toxicol. 2015 Feb;45(2):172-83. doi: 10.3109/10408444.2014.986054. Epub 2015 Jan 23. Review.

PMID:
25615431
19.

ATR inhibitors VE-821 and VX-970 sensitize cancer cells to topoisomerase i inhibitors by disabling DNA replication initiation and fork elongation responses.

Jossé R, Martin SE, Guha R, Ormanoglu P, Pfister TD, Reaper PM, Barnes CS, Jones J, Charlton P, Pollard JR, Morris J, Doroshow JH, Pommier Y.

Cancer Res. 2014 Dec 1;74(23):6968-79. doi: 10.1158/0008-5472.CAN-13-3369. Epub 2014 Sep 30.

20.

Asymmetric connectivity of spawning aggregations of a commercially important marine fish using a multidisciplinary approach.

Munguia-Vega A, Jackson A, Marinone SG, Erisman B, Moreno-Baez M, Girón-Nava A, Pfister T, Aburto-Oropeza O, Torre J.

PeerJ. 2014 Aug 7;2:e511. doi: 10.7717/peerj.511. eCollection 2014.

21.

[Phytotherapy in geriatrics and gerontology].

Saller R, Kasper S, Dimpfel W, Savaskan E, Pfister T, Rostock M, Witt C, Thuile C, Das O, Unger M.

Forsch Komplementmed. 2014;21 Suppl 1:2-18. doi: 10.1159/000362393. Epub 2014 Jul 4. German. No abstract available.

22.

Bioavailability of therapeutic proteins by inhalation--worker safety aspects.

Pfister T, Dolan D, Bercu J, Gould J, Wang B, Bechter R, Barle EL, Pfannkuch F, Flueckiger A.

Ann Occup Hyg. 2014 Aug;58(7):899-911. doi: 10.1093/annhyg/meu038. Epub 2014 Jun 23. Review.

PMID:
24958792
23.

Identifying the elusive sites of tyrosyl radicals in cytochrome c peroxidase: implications for oxidation of substrates bound at a site remote from the heme.

Miner KD, Pfister TD, Hosseinzadeh P, Karaduman N, Donald LJ, Loewen PC, Lu Y, Ivancich A.

Biochemistry. 2014 Jun 17;53(23):3781-9. doi: 10.1021/bi500353p. Epub 2014 Jun 5.

24.

Energy cost of running and Achilles tendon stiffness in man and woman trained runners.

Fletcher JR, Pfister TR, Macintosh BR.

Physiol Rep. 2013 Dec 6;1(7):e00178. doi: 10.1002/phy2.178. eCollection 2013 Dec 1.

25.

EPITOME-2: An open-label study assessing the transition to a new formulation of intravenous epoprostenol in patients with pulmonary arterial hypertension.

Sitbon O, Delcroix M, Bergot E, Boonstra AB, Granton J, Langleben D, Subías PE, Galiè N, Pfister T, Lemarié JC, Simonneau G.

Am Heart J. 2014 Feb;167(2):210-7. doi: 10.1016/j.ahj.2013.08.007. Epub 2013 Oct 3.

26.

Registry data storage and curation.

Johnston M, Campbell C, Hayward R, Lowerison M, Noonan VK, Pfister T, Maxwell C, Fortin CM, Smith EE, Mah JK, Kapral MK, Jette N, Pringsheim T, Korngut L.

Can J Neurol Sci. 2013 Jul;40(4 Suppl 2):S35-40. Review. No abstract available.

PMID:
23787265
27.

Neurological registry data collection methods and configuration.

Smith EE, Warner J, Johnston M, Atwood K, Hall R, Mah JK, Maxwell C, Fortin CM, Lowerison M, Kapral MK, Noonan VK, Pfister T, Mackean G, Casselman L, Pringsheim T, Jette N, Korngut L.

Can J Neurol Sci. 2013 Jul;40(4 Suppl 2):S27-31. Review. No abstract available.

PMID:
23787263
28.

Can muscle shortening alone, explain the energy cost of muscle contraction in vivo?

Fletcher JR, Groves EM, Pfister TR, Macintosh BR.

Eur J Appl Physiol. 2013 Sep;113(9):2313-22. doi: 10.1007/s00421-013-2665-0. Epub 2013 May 28.

PMID:
23712215
29.

Displacement, distance, and shape measurements of fast-rotating rough objects by two mutually tilted interference fringe systems.

Günther P, Kuschmierz R, Pfister T, Czarske JW.

J Opt Soc Am A Opt Image Sci Vis. 2013 May 1;30(5):825-30. doi: 10.1364/JOSAA.30.000825.

PMID:
23695313
30.

Effect of GLP1R agonists taspoglutide and liraglutide on primary thyroid C-cells from rodent and man.

Boess F, Bertinetti-Lapatki C, Zoffmann S, George C, Pfister T, Roth A, Lee SM, Thasler WE, Singer T, Suter L.

J Mol Endocrinol. 2013 Apr 12;50(3):325-36. doi: 10.1530/JME-12-0186. Print 2013 Jun.

PMID:
23463748
31.

A multi-histology trial of fostamatinib in patients with advanced colorectal, non-small cell lung, head and neck, thyroid, and renal cell carcinomas, and pheochromocytomas.

Park SR, Speranza G, Piekarz R, Wright JJ, Kinders RJ, Wang L, Pfister T, Trepel JB, Lee MJ, Alarcon S, Steinberg SM, Collins J, Doroshow JH, Kummar S.

Cancer Chemother Pharmacol. 2013 Apr;71(4):981-90. doi: 10.1007/s00280-013-2091-3. Epub 2013 Feb 13.

32.

Guidance on the establishment of acceptable daily exposure limits (ADE) to support Risk-Based Manufacture of Pharmaceutical Products.

Sargent EV, Faria E, Pfister T, Sussman RG.

Regul Toxicol Pharmacol. 2013 Mar;65(2):242-50. doi: 10.1016/j.yrtph.2012.12.007. Epub 2013 Jan 3.

PMID:
23291300
33.

Familial amyotrophic lateral sclerosis in Alberta, Canada.

Pfister T, Sekhon R, White M, Scott P, Munro S, Johnston M, Kalra S, Korngut L.

Amyotroph Lateral Scler Frontotemporal Degener. 2013 May;14(4):273-7. doi: 10.3109/21678421.2012.754044. Epub 2013 Jan 4.

PMID:
23286750
34.

Development and validation of an immunoassay for quantification of topoisomerase I in solid tumor tissues.

Pfister TD, Hollingshead M, Kinders RJ, Zhang Y, Evrard YA, Ji J, Khin SA, Borgel S, Stotler H, Carter J, Divelbiss R, Kummar S, Pommier Y, Parchment RE, Tomaszewski JE, Doroshow JH.

PLoS One. 2012;7(12):e50494. doi: 10.1371/journal.pone.0050494. Epub 2012 Dec 28.

35.

Determination of renal tissue ibandronate levels in rats with normal and mildly impaired renal function.

Bergner R, Siegrist B, Kränzlin B, Gretz N, Faust H, Pfister T.

J Pharmacol Toxicol Methods. 2013 Sep-Oct;68(2):225-230. doi: 10.1016/j.vascn.2012.12.001. Epub 2012 Dec 20.

PMID:
23261819
36.

Distance measurement technique using tilted interference fringe systems and receiving optic matching.

Günther P, Kuschmierz R, Pfister T, Czarske J.

Opt Lett. 2012 Nov 15;37(22):4702-4.

PMID:
23164885
37.

NANOG modulates stemness in human colorectal cancer.

Zhang J, Espinoza LA, Kinders RJ, Lawrence SM, Pfister TD, Zhou M, Veenstra TD, Thorgeirsson SS, Jessup JM.

Oncogene. 2013 Sep 12;32(37):4397-405. doi: 10.1038/onc.2012.461. Epub 2012 Oct 22.

38.

Lipopolysaccharide pretreatment of the udder protects against experimental Escherichia coli mastitis.

Petzl W, Günther J, Pfister T, Sauter-Louis C, Goetze L, von Aulock S, Hafner-Marx A, Schuberth HJ, Seyfert HM, Zerbe H.

Innate Immun. 2012 Jun;18(3):467-77. doi: 10.1177/1753425911422407. Epub 2011 Oct 11.

PMID:
21990573
39.

Exon array analyses across the NCI-60 reveal potential regulation of TOP1 by transcription pausing at guanosine quartets in the first intron.

Reinhold WC, Mergny JL, Liu H, Ryan M, Pfister TD, Kinders R, Parchment R, Doroshow J, Weinstein JN, Pommier Y.

Cancer Res. 2010 Mar 15;70(6):2191-203. doi: 10.1158/0008-5472.CAN-09-3528. Epub 2010 Mar 9.

40.

Monitoring drug-induced gammaH2AX as a pharmacodynamic biomarker in individual circulating tumor cells.

Wang LH, Pfister TD, Parchment RE, Kummar S, Rubinstein L, Evrard YA, Gutierrez ME, Murgo AJ, Tomaszewski JE, Doroshow JH, Kinders RJ.

Clin Cancer Res. 2010 Feb 1;16(3):1073-84. doi: 10.1158/1078-0432.CCR-09-2799. Epub 2010 Jan 26.

41.

Literature review on the genotoxicity, reproductive toxicity, and carcinogenicity of ethyl methanesulfonate.

Gocke E, Bürgin H, Müller L, Pfister T.

Toxicol Lett. 2009 Nov 12;190(3):254-65. doi: 10.1016/j.toxlet.2009.03.016. Epub 2009 Mar 28. Review.

PMID:
19857796
42.

Topoisomerase I levels in the NCI-60 cancer cell line panel determined by validated ELISA and microarray analysis and correlation with indenoisoquinoline sensitivity.

Pfister TD, Reinhold WC, Agama K, Gupta S, Khin SA, Kinders RJ, Parchment RE, Tomaszewski JE, Doroshow JH, Pommier Y.

Mol Cancer Ther. 2009 Jul;8(7):1878-84. doi: 10.1158/1535-7163.MCT-09-0016. Epub 2009 Jul 7.

43.

Ethyl methanesulfonate toxicity in Viracept--a comprehensive human risk assessment based on threshold data for genotoxicity.

Müller L, Gocke E, Lavé T, Pfister T.

Toxicol Lett. 2009 Nov 12;190(3):317-29. doi: 10.1016/j.toxlet.2009.04.003. Epub 2009 Apr 10.

PMID:
19443141
44.

General 4-week toxicity study with EMS in the rat.

Pfister T, Eichinger-Chapelon A.

Toxicol Lett. 2009 Nov 12;190(3):271-85. doi: 10.1016/j.toxlet.2009.04.031. Epub 2009 May 13.

PMID:
19442710
45.

EMS in Viracept--initial ('traditional') assessment of risk to patients based on linear dose response relations.

Gocke E, Müller L, Pfister T.

Toxicol Lett. 2009 Nov 12;190(3):266-70. doi: 10.1016/j.toxlet.2009.04.030. Epub 2009 May 9.

PMID:
19439165
46.

Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial.

Senti G, Johansen P, Haug S, Bull C, Gottschaller C, Müller P, Pfister T, Maurer P, Bachmann MF, Graf N, Kündig TM.

Clin Exp Allergy. 2009 Apr;39(4):562-70. doi: 10.1111/j.1365-2222.2008.03191.x. Epub 2009 Feb 16.

PMID:
19226280
47.

Laser Doppler distance sensor using phase evaluation.

Günther P, Pfister T, Büttner L, Czarske J.

Opt Express. 2009 Feb 16;17(4):2611-22.

PMID:
19219164
48.

Renal tolerability of intermittent intravenous ibandronate treatment for patients with postmenopausal osteoporosis: a review.

Miller PD, Ward P, Pfister T, Leigh C, Body JJ.

Clin Exp Rheumatol. 2008 Nov-Dec;26(6):1125-33. Review.

PMID:
19210886
49.
50.

Ibandronate uptake in the jaw is similar to long bones and vertebrae in the rat.

Bauss F, Pfister T, Papapoulos S.

J Bone Miner Metab. 2008;26(4):406-8. doi: 10.1007/s00774-007-0837-x. Epub 2008 Jul 4.

PMID:
18600409

Supplemental Content

Loading ...
Support Center